Zura Bio Limited (ZURA)
(Delayed Data from NSDQ)
$4.13 USD
-0.05 (-1.20%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $4.12 -0.01 (-0.24%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum F VGM
Price, Consensus and EPS Surprise
ZURA 4.13 -0.05(-1.20%)
Will ZURA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ZURA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ZURA
Wall Street Analysts Predict a 235.2% Upside in Zura Bio Limited (ZURA): Here's What You Should Know
How Much Upside is Left in Zura Bio Limited (ZURA)? Wall Street Analysts Think 248.84%
ZURA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zura Bio Limited (ZURA) Upgraded to Buy: Here's What You Should Know
Other News for ZURA
Zura Bio GAAP EPS of -$0.17
Three new option listings and one option delisting on August 14th
Zura Bio Releases Updated Corporate Presentation Info
ZURA Stock Earnings: Zura Bio Misses EPS for Q2 2024
Zura Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights